アルゼンチンにおけるアルツハイマー病に焦点を当てた早期認知症診断のためのコンセンサス。プライマリケアおよび専門医向け。診断基準とアルゴリズムを更新。
Pablo M Bagnati1, Ricardo F Allegri2, Ignacio Demey3
1Investigador principal y coordinador de la Sección de Neuropsiquiatría, Servicio de Neurología Cognitiva, Fleni, Bs. As., Argentina.. pablombagnati@gmail.com.
まとめ
このコンセンサスは、プライマリケア医および専門医が早期に認知症を発見するための診断ツールを提供します。アルツハイマー病に焦点を当て、典型的な加齢との鑑別、診断アルゴリズム、評価について概説します。
科学分野:
- 神経学; 老年医学; 精神医学
背景:
- 認知症の診断は、プライマリケアおよび専門医にとって課題となります。
- 認知症、特にアルツハイマー病の早期かつ正確な診断は極めて重要です。
研究 の 目的:
- 早期認知症検出のための効率的な診断ツールの開発。
- プライマリケア医および専門医のための最新の診断基準とアルゴリズムの提供。
- 西洋諸国で最も一般的な認知症であるアルツハイマー病への焦点。
主な方法:
- 専門家委員会による5か月間のレビュー(2024年8月~12月)とその後の更新。
- 現在のエビデンスと診断情報の分析と議論。
- 神経認知、神経精神医学、バイオマーカー、機能評価を含む診断体系的アプローチの開発。
主要な成果:
- コンセンサス文書は3つの部分に分かれています:現在の認知症の状況、診断評価の体系、および鑑別診断を伴う認知症の種類。プライマリケアおよび専門医向けの診断アルゴリズムが含まれています。神経認知、神経精神医学、バイオマーカー(検査、CSF、血漿、神経画像、遺伝学)、および機能評価を詳述しています。
結論:
- アルゼンチン認知症診断コンセンサスは、早期検出のための構造化されたアプローチを提供します。
- 典型的な加齢と認知症の鑑別の重要性を強調しています。
- この文書は、認知症患者を管理する臨床医のための包括的なガイドとして機能します。
関連する概念動画
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


